West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3032% above fair value
$416.42+5.12 (+1.24%)
Close on Nov 13, 2026Market cap $29.01BP/E 46.7Yield 0.21%
West Pharmaceutical Services EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
West Pharmaceutical Services's EV/EBITDA was 33.5× on Nov 11, 2026, against 25.9× a year earlier. Over the last 5 years it ranged from 20.7× to 50.1×, with a median of 32.7×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 33.5× | +7.8 |
| 2025 | Dec 31, 2025 | 25.7× | −15.4 |
| 2024 | Dec 31, 2024 | 41.1× | +1.7 |
| 2023 | Dec 29, 2023 | 39.3× | +17.9 |
| 2022 | Dec 30, 2022 | 21.4× | −28.7 |
| 2021 | Dec 31, 2021 | 50.1× | −5.9 |
| 2020 | Dec 31, 2020 | 56.0× | +17.6 |
| 2019 | Dec 31, 2019 | 38.4× | +7.9 |
| 2018 | Dec 31, 2018 | 30.5× | −2.9 |
| 2017 | Dec 29, 2017 | 33.4× | +0.2 |
| 2016 | Dec 30, 2016 | 33.2× | −1.1 |
| 2015 | Dec 31, 2015 | 34.3× | +12.0 |
| 2014 | Dec 31, 2014 | 22.3× | −0.6 |
| 2013 | Dec 31, 2013 | 22.9× | +5.8 |
| 2012 | Dec 31, 2012 | 17.0× | −0.9 |
| 2011 | Dec 30, 2011 | 18.0× | +1.2 |
| 2010 | Dec 31, 2010 | 16.7× | +6.0 |
| 2009 | Dec 31, 2009 | 10.7× | – |
See a number that looks wrong?